Press Release

Biological Skin Substitutes Market to be Dominated by the Human Donor Tissue-Derived Products through 2028

Increasing adoption of regenerative medicine techniques and rising incidences of chronic wounds is expected to drive the growth of global Biological Skin Substitutes market during the forecast period, 2024-2028.

According to TechSci Research report, “Biological Skin Substitutes Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028”, Biological Skin Substitutes Market is expected to grow during the forecast period of 2024-2028. owing to the increasing incidences of chronic wounds, growing geriatric population, and increasing adoption of regenerative medicine techniques.

However, there are several challenges that will hamper the growth of Biological Skin Substitutes market in coming years. These challenges are high cost of product, regulatory issues, lack of awareness, and competition from alternative treatment modalities.

The COVID-19 pandemic has had a significant impact on the global biological skin substitutes market. While the market was growing steadily prior to the pandemic, the outbreak has led to a number of challenges and disruptions, including supply chain disruptions, decreased demand, and delays in clinical trials and regulatory approvals.

One of the biggest impacts of the pandemic on the biological skin substitutes market has been the disruption to the global supply chain. Many manufacturers of biological skin substitutes rely on raw materials from countries that were hit hard by the pandemic, such as China and India. As the countries-imposed lockdowns and restrictions on travel and trade, it became more difficult for manufacturers to obtain the materials they needed, leading to supply shortages and delays.


Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Biological Skin Substitutes Market"


Global Biological Skin Substitutes market can be segmented on the basis of type, application, end user, and region.

Based on type, the market can be further divided into human donor tissue-derived products, acellular animal derived products, and biosynthetic products. Human Donor Tissue-derived products are expected to dominate the global biological skin substitute market during the forecast period owing to their high success rate. Human donor tissue-derived products have a high success rate in terms of engraftment and healing. This is due to their similarity to human skin and their ability to integrate into the recipient's tissue. Human donor tissue-derived products have been used for skin replacement for decades and are well-established as a safe and effective treatment option. This has helped to build trust and confidence in their use among physicians and patients. Human donor tissue-derived products are often less expensive than other options, such as synthetic skin substitutes. This makes them a more accessible option for patients who may not be able to afford more expensive treatments.

Global biological skin substitutes market is divided into chronic wounds and acute wounds, based on application. Chronic wounds are expected to dominate the global market of biological skin substitutes in coming years. Chronic wounds, such as diabetic foot ulcers, venous leg ulcers, and pressure ulcers, are a growing healthcare concern around the world. These wounds can be difficult to treat and may take months or even years to heal. In recent years, there has been a growing interest in the use of biological skin substitutes to help accelerate wound healing and reduce the risk of infection. Additionally, advances in technology and research have led to the development of increasingly sophisticated biological skin substitutes that are better able to meet the unique needs of chronic wounds. For example, some products contain growth factors that stimulate the growth of new tissue, while others incorporate antimicrobial agents to reduce the risk of infection. As these products become more widely available and more effective, they are likely to become the treatment of choice for many physicians and patients.

Major companies operating in global Biological Skin Substitutes market are:

  • Smith & Nephew, plc
  • 3M Company
  • Organogenesis, Inc.
  • Stratatech Corporation
  • Integra LifeSciences Corporation
  • Tissue Regenix Group
  • Mimedx Group

 

Download Free Sample Report

Customers can also request for 10% free customization on this report.

 

“The global biological skin substitutes market is a rapidly growing industry that includes a variety of products designed to promote wound healing and tissue regeneration. These products are derived from a variety of sources, including human donor tissue, animal tissue, and synthetic materials, and are used to treat a wide range of conditions, including burns, chronic wounds, and surgical wounds. While the market has faced some challenges in recent years, including disruptions to the global supply chain and decreased demand due to the COVID-19 pandemic, it is expected to continue to grow in the coming years, driven by increasing demand for effective wound care treatments and advances in technology and research,” said Mr. Karan Chechi, Research Director with TechSci Research, a research- based global management consulting firm.

“Biological Skin Substitutes Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028, Segmented By Type (Human Donor Tissue-Derived Products, Acellular Animal Derived Products, Biosynthetic Products), By Application (Chronic Wounds v/s Acute Wounds), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), Region and Competition”, has evaluated the future growth potential of Global Biological Skin Substitutes Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Biological Skin Substitutes Market.


Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email:  [email protected]

Website: www.techsciresearch.com

Relevant News